Concepedia

MicroRNA-132 Modulates Cholinergic Signaling and Inflammation in Human Inflammatory Bowel Disease

Nitsan Maharshak, Shani Shenhar‐Tsarfaty, Nimrod Aroyo, Naama Orpaz, Irene Guberman, Jonathan Canaani, Zamir Halpern, Iris Dotan, Shlomo Berliner, Hermona Soreq

Inflammatory Bowel Diseases · 2013 · 72 citations · 31 references

DOIFull text

Open access

Abstract

Taken together, these findings support an inflammation-dependent homeostatic role for the regulation by miR-132 of AChE in IBD, opening new venues for therapeutic interference.

References

31

A new and rapid colorimetric determination of acetylcholinesterase activity

George L. Ellman, K. Diane Courtney, Valentino Andres et al. · Biochemical Pharmacology · 1961 · 26.6K citations

, , +4

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.1K citations

, , +5

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.8K citations · Full text

Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation

Hong Wang, Man Yu, Mahendar Ochani et al. · Nature · 2002 · 3.1K citations

, , +9

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · New England Journal of Medicine · 2010 · 3.1K citations · Full text